InMed Pharmaceuticals Inc. (INM)
NASDAQ: INMHealthcareDrug Manufacturers - Specialty & GenericUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
INM stock chart
Technical analysisKey statistics
All statistics- Market cap
- $7.31M
- EPS (TTM)
- -$2.85
- Dividend yield
- None
- 52-week range
- 0.575 – 2.40
- Day range
- 1.32 – 1.36
- Volume / Avg
- 26.76K / 914.23K
- Beta
- —
- Shares outstanding
- 5.49M
- Next earnings
- Nov 5, 2026
52-week range
INM stock today
InMed Pharmaceuticals (INM) closed at $1.33 on Oct 8, essentially unchanged from the prior close, versus the S&P 500's 0.47% decline. Trading was light, with 26.76K shares changing hands, about 3% of the average daily volume. At this level, INM sits in the middle of its 52-week range of $0.575 to $2.40: 44.6% below the high and 131.3% above the low.
InMed Pharmaceuticals has posted a net loss over the last twelve months (EPS of -$2.85), so its P/E ratio is not meaningful. InMed Pharmaceuticals's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About InMed Pharmaceuticals
Company profileInMed Pharmaceuticals Inc. operates as a pharmaceutical drug development company in the United States. The company researches and develops cannabinoid-based pharmaceuticals products.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Eric A. Adams B.S. Chem., M.I.B.
- Headquarters
- Vancouver, BC
- Employees
- 6
- Website
- inmedpharma.com
Earnings
Earnings history- Next report
- Nov 5, 2026
InMed Pharmaceuticals peers
Healthcare sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| APUSApimeds Pharmaceuticals US Inc. | 5.51 | -21.84% | $8.32M | vs INM |
| GELSGelteq Limited | 0.5488 | -1.98% | $5.88M | vs INM |
| SNOASonoma Pharmaceuticals Inc. | 1.16 | -4.92% | $5.55M | vs INM |
| RDHLRedhill Biopharma Ltd. ADR | 0.578 | +21.94% | $5.14M | vs INM |
| AKANAkanda Corp. | 1.78 | -7.77% | $4.70M | vs INM |
| YCBDcbdMD Inc. | 0.3948 | -3.00% | $4.42M | vs INM |
| PRFXPRF Technologies Ltd. | 0.8587 | -2.16% | $3.00M | vs INM |
| IMCCIM Cannabis Corp. | 1.72 | -9.47% | $2.83M | vs INM |
Indexes, lists and sector
Appears in lists
InMed Pharmaceuticals stock FAQ
What is InMed Pharmaceuticals's stock price today?
INM last traded at $1.33 as of Oct 8, 4:00 PM EDT, up 0.00% on the day. Prices are delayed at least 15 minutes.
When is InMed Pharmaceuticals's next earnings date?
InMed Pharmaceuticals is expected to report earnings on Thursday, November 5, 2026.
Who is InMed Pharmaceuticals's CEO?
Mr. Eric A. Adams B.S. Chem., M.I.B. is the chief executive officer of InMed Pharmaceuticals Inc., which has about 6 employees.
What is the INM 52-week high?
The 52-week high for INM is $2.40 and the 52-week low is $0.575. The stock is currently 44.6% below its high.